A detailed history of Axq Capital, LP transactions in Pfizer Inc stock. As of the latest transaction made, Axq Capital, LP holds 25,450 shares of PFE stock, worth $638,286. This represents 0.25% of its overall portfolio holdings.

Number of Shares
25,450
Previous 12,829 98.38%
Holding current value
$638,286
Previous $311 Million 108.53%
% of portfolio
0.25%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$23.29 - $25.88 $293,943 - $326,631
12,621 Added 98.38%
25,450 $648 Million
Q2 2025

Aug 12, 2025

BUY
$21.59 - $24.84 $276,978 - $318,672
12,829 New
12,829 $311 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $43,344 - $50,148
1,200 Added 11.54%
11,600 $425 Million
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $497,298 - $647,410
-12,625 Reduced 54.83%
10,400 $424 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $961,293 - $1.25 Million
23,025 New
23,025 $1.18 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.